Numerous studies have demonstrated that endothelial cells are capable of undergoing
endothelial to mesenchymal transition (EndMT), a newly recognized type of cellular …

Cell transdifferentiation occurs during cardiovascular development or remodeling either as a
pathologic feature in the progression of disease or as a response to injury. Endothelial-to …

During the last decade, the endothelial-to-mesenchymal transition (EndMT) process has
attracted considerable attention due to associations with the onset of certain diseases, such …

Endothelial to mesenchymal transition (EndMT) is a special type of epithelial to
mesenchymal transition. It is a process that is characterized by the loss of features of …

Endothelial-to-mesenchymal transition (EndMT) is a complex biological process in which
endothelial cells lose their specific markers and acquire a mesenchymal or myofibroblastic …

Endothelial-to-mesenchymal transition is a dynamic process in which endothelial cells
suppress constituent endothelial properties and take on mesenchymal cell behaviors. To …

Epithelial–mesenchymal transition is an important developmental process, participates in
tumor's formation, invasion, and metastasis and has been extensively studied. Recently …

Atherosclerosis is a fundamental disease of the cardiovascular system that leads to high
morbidity and mortality worldwide. The endothelium is the first protective barrier in …

Endothelial‐to‐mesenchymal transition (EndMT) was first reported in the embryogenesis.
Recent studies show that EndMT also occurs in the disease progression of atherosclerosis …

Endothelial cells (ECs) have been found to be capable of acquiring a mesenchymal
phenotype through a process known as endothelial-to-mesenchymal transition (EndMT) …